Life sciences · Preprint
arXiv · September 30, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Open-weight LLMs are released not only as fixed products but also as substrates for downstream fine-tuning. This openness, however, creates legal and ethical risks because users may misuse fine-tuning to instill illicit knowledge or enable hostile operations. Model providers therefore need apre-release defense against such acquisition, motivating the problem of preemptive unlearning. Unlike retrospective unlearning, which removes capabilities already present in a fixed model, preemptive unlearning seeks to prevent their acquisition under unseen attack data and future fine-tuning procedures. Despite its practical importance, this setting remains largely unexplored, presents distinct challenges, and is therefore the central focus of our work. We first verify that existing retrospective methods provide insufficient pre-release protection. Even when forbidden capabilities are suppressed in current outputs, forbidden-domain data can still induce gradients through internal pathways, enabling later acquisition. Motivated by this finding, we propose a gradient-sealing principle that blocks these pathways by pushing relevant pre-activations into the negative region, where ReLU-family activations exhibit zero or near-zero derivatives. Experiments across multiple LLM families demonstrate our stronger resistance to downstream acquisition than retrospective baselines, validating gradient sealing as an effective mechanism for pre-release protection.